Podcasts about epro

Kent Redding's path from retail mogul to real estate powerhouse isn't what you'd expect - especially when leadership, empathy, and branding collide. In this episode, Kent shares the surprising lessons he learned that still shape his business today. You'll walk away rethinking what it really means to build trust, show up, and lead with heart. Plus, don't miss the story of the open house that literally caused a traffic jam.   Key takeaways to listen for How Kent turned personal values into a business branding strategy that stuck What managing 400 retail employees teaches you about long-term client loyalty The marketing wisdom that still drives Kent's success today Reasons self-awareness and empathy matter more than market trends Is volunteering with your local REALTOR® association a great career move?   About Kent ReddingKent is a top-producing REALTOR®, 2024 President of the Austin Board of REALTORS®, and a 20-year veteran with Berkshire Hathaway. Known for his client-first approach, Kent combines entrepreneurial grit with a deep commitment to the community. He's a ten-time Platinum Top 50 award winner and holds designations including GRI, CRS, ABR, ePro, MRP, and CLHMS. Outside of real estate, Kent volunteers with groups like Community First! Village, Hungry Souls, and Red Oak Hope.   Connect with Kent Website: Kent Redding Facebook: Kent Redding | Kent Redding Team Instagram: @kentreddinggroup LinkedIn: Kent Redding Email: kent@callkent.com Contact Number: (512) 797-5737   Connect with LeighPlease subscribe to this podcast on your favorite podcast app at https://pod.link/1153262163, and never miss a beat from Leigh by visiting https://leighbrown.com. DM Leigh Brown on Instagram @ LeighThomasBrown.   Sponsors"You Ask. Leigh Answers." Your Affordable Coaching ProgramHey there, real estate pros! Are you ready for some more Leigh Brown wisdom in your life? Then don't miss out on my brand-new program, "You Ask. Leigh Answers." It's your exclusive gateway to the insights and advice you need to supercharge your real estate business. With "You Ask. Leigh Answers." you get Direct Access to Leigh Brown, directly! Expert Coaching, Community Connection, and Extensive Resources. Whether listening to this on the go or watching at home, sign up today at Answers.RealEstate and take your business to the next level. Trust me, you'll be glad you did!  

What happens when disaster strikes and traditional relief efforts fall short? In this episode, Leigh Brown teams up with Eric Kistner to discuss the challenges of Western North Carolina's housing crisis and the innovative solutions to helping displaced families. Plus, hear the story of black mold-infested campers meant for disaster relief and how temporary tractor sheds became an unexpected lifesaver. Tune in for inspiration and a fresh perspective on making a difference!     Key takeaways to listen for How a simple idea evolved into an effective housing solution for displaced families Understanding the limitations of FEMA, flood insurance, and bureaucratic red tape How ordinary people can mobilize resources faster than large organizations Ways to leverage real estate networks to coordinate relief and rebuild communities Practical steps listeners can take to support ongoing relief efforts and make a tangible impact     Resources mentioned in this episode FEMA Patriot Relief Facebook TikTok National Association of REALTORS®     About Eric Kistner Eric is a Business Coach and Tennessee Real Estate Academy Owner & Director of Instruction. With a degree in economics and political science from King University, Eric is the managing broker of Bridge Pointe Real Estate and Auction. He brings a unique perspective to the local real estate market as a licensed broker, contractor, and auctioneer. He served as the 2017 president of the Northeast Tennessee Real Estate Association of REALTORS®, and in 2018, he was honored with the prestigious Netar REALTOR® of the Year Award. He's a graduate of the National Association of Realtors® Leadership Academy and is committed to lifelong learning.   Eric holds several real estate designations, including CRS, GRI, EPRO, NCC, and RCC. He's also a certified real estate coach by Leigh Brown, a certified Distance Education instructor, and a certified Tennessee education instructor. Beyond his professional achievements, Eric actively contributes to his community. He serves as the chairman of the Holston Valley Medical Center and is a founding member of the HVMC Patient Advisory Task Force. He's also a valued board member for the Move to Kingsport and Kingsport Façade Grant Committees.     Connect with Eric Website: Tennessee Real Estate Academy Facebook: Mattress Outlet Email: ekistner14@gmail.com     Connect with Leigh Please subscribe to this podcast on your favorite podcast app at https://pod.link/1153262163, and never miss a beat from Leigh by visiting https://leighbrown.com. DM Leigh Brown on Instagram @ LeighThomasBrown.     Sponsors "You Ask. Leigh Answers." Your Affordable Coaching Program Hey there, real estate pros! Are you ready for some more Leigh Brown wisdom in your life? Then don't miss out on my brand-new program, "You Ask. Leigh Answers." It's your exclusive gateway to the insights and advice you need to supercharge your real estate business. With "You Ask. Leigh Answers." you get Direct Access to Leigh Brown, directly! Expert Coaching, Community Connection, and Extensive Resources. Whether listening to this on the go or watching at home, sign up today at Answers.RealEstate and take your business to the next level. Trust me, you'll be glad you did!  

For more information, go to theconferenceforum.org

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.EPRO, or electronic patient-reported outcomes, is increasingly used in clinical trials to improve data accuracy, patient compliance, and reduce administrative burdens. Swing Therapeutics achieved 98% patient compliance in their pilot trial using EPRO, leading to an FDA de novo marketing authorization. EPRO boosts efficiency, saves costs, and improves trial outcomes.The BioSecure Act, which restricts contracts with certain Chinese companies in the US biotech industry, has advanced in the House but still needs Senate support. Bain Capital closed a $3 billion biotech fund and has been acquiring startup companies. Centessa's sleepiness drug showed promising results, lifting the company's shares. New data raise doubts about AstraZeneca and Daiichi's cancer treatment successor. Candid aims to prove the worth of bispecifics in autoimmune diseases.Roivant Sciences has acquired the rights to develop and commercialize Bayer's pulmonary hypertension drug, Mosliciguat, under an in-license agreement worth up to $294 million. Roivant has created a new "vant" called Vant to focus on this project. The Biosecure Act has passed through the U.S. House of Representatives and is set for a Senate vote. AstraZeneca and Daiichi Sankyo's Dato-Dxd failed to significantly improve overall survival in Phase III NSCLC trials, but there is still potential for FDA approval. Terns Pharmaceuticals announced a $125 million raise following positive Phase I data for their oral GLP-1 candidate for obesity.Old Navy is celebrating its 30th anniversary by throwing back to the '90s in a new collection and campaign to enhance its iconic brand. PayPal has launched its largest-ever US ad campaign featuring Will Ferrell, promoting the use of PayPal for both in-store and online transactions. Angela Zepeda, former Hyundai CMO, has been appointed as the global head of marketing for X. Pizza Hut is turning TikTok content into real-world currency for a promotion in the UAE, while Target is targeting pet owners with a collection designed by "fur-fluencers." Marketers are leveraging AI on mobile platforms and genAI is impacting marketing strategies.Merck's Keytruda, a leading immuno-oncology drug, has been highly successful in treating various cancers and has become the world's top-selling drug. However, determining the true value of a drug like Keytruda involves more than just sales numbers. U.S. drug pricing watchdog ICER tracks pricing decisions and their impact, but the industry is exploring new methods to factor in aspects like disability and income disparity. A new formula that considers "standard of living" is being explored to offer a different perspective on pricing in the pharmaceutical industry. As Keytruda celebrates its 10-year anniversary on the market, the impact of this cancer drug and other immunotherapies is being analyzed, along with the future direction of the field.

Společnost ČEPRO, kde je jediným akcionářem ministerstvo financí, koupila za 4,5 miliardy síť 75 čerpacích stanic společnosti Robin Oil. Kolem transakce bylo nebývalé ticho a mezi vládními ministry panuje nesoulad v tom, kdo o nákupu věděl. Šedá místa rozkryl Jan Novotný z e15. Proto byl hostem Martina Bartkovského v pořadu Prostor X, kde rozebírá všechny detaily státního nákupu. Bylo to pro stát výhodné a kolik to nakonec celé stálo? Nejen to se dozvíte v rozhovoru.

Za jakých podmínek kupuje státní společnost Čepro síť čerpacích stanic Robin Oil? Jaké požadavky provázejí v řadě unijních zemí rozsáhlé protestní akce farmářů a promítnou se i do společné zemědělské politiky evropské sedmadvacítky? A proč vyvolává tak mimořádné ohlasy, nejen ve světě Formule 1, ohlášený přechod sedminásobného šampiona Lewise Hamiltona ze stáje Mercedesu k Ferrari?

Za jakých podmínek kupuje státní společnost Čepro síť čerpacích stanic Robin Oil? Jaké požadavky provázejí v řadě unijních zemí rozsáhlé protestní akce farmářů a promítnou se i do společné zemědělské politiky evropské sedmadvacítky? A proč vyvolává tak mimořádné ohlasy, nejen ve světě Formule 1, ohlášený přechod sedminásobného šampiona Lewise Hamiltona ze stáje Mercedesu k Ferrari?Všechny díly podcastu Hlavní zprávy - rozhovory a komentáře můžete pohodlně poslouchat v mobilní aplikaci mujRozhlas pro Android a iOS nebo na webu mujRozhlas.cz.

This weekend I am in Taupo – basically to celebrate a Company that has been trapping vermin and exotic pests to create predator-free forests and landscapes. EPRO is their name and they have been doing it for 25 Years – worthy of serious congratulations! They literally provide long-term strategies for ecological restoration. Many of our Native taonga (but especially birds) are in trouble; Often stories in the news – such as the famous Miami Kiwi: Paora was the kiwi that became famous for all the wrong reasons; but not because it was predated by exotic mammals. For some reason we got upset because humans were touching the bird and stressing it far too much. The irony is that around the same time, a kiwi was found, Mauled to death by a dog in Ohope (Whakatane). Yes, a Dog! And the dead kiwi was found behind Ohope Beach school, not just a forest in the middle of nowhere. That bird was also one of the important ancestors for the next generation of kiwi in that area! A set-back for the Whakatane Kiwi Trust. Not many people realise that dogs are the biggest threat to kiwi in habitat around human settlements.   Kiwi smell is very attractive to dogs… and dogs will have a go (yes, Ma'am: even your tiny lap dog will chase that bird!) They may not necessarily want to eat or bite the bird, but just a paw on the back of the kiwi can cause serious crushing troubles; Kiwi have no sternum (breastbone) for the simple reason they don't have wings and don't need a sternum to attach flight muscles to. That makes them very vulnerable to crushing from dog bites and pressure from above. They literally bleed to death internally. So EPRO can control stoats and ferrets and rats and feral cats, but when Homo sapiens goes for a walk in the forest with an UN-leashed dog, kiwi are often the victims. And please don't tell me your little cute Roly will not harm anything …. A totally different way to look after our native birds, is by supporting the science that's going on throughout the Motu: We are currently banding Harriers (Harrier-Hawks)… or “Large Piwakawaka” as I call them… These birds are banded in Canterbury and Marlborough: a small metal band on one leg, (the usual DOC band with small numbers on them), and a larger brightly coloured band with large, three digit numbers on them, that can be read through binoculars from quite far away, when the bird is sitting on a fence post or feasting on road kill. We are hoping to confirm that these harriers are doing some migrating in autumn and spring (towards the North and South, respectively). If you find a banded bird, record the date and location and report to DOC: www.doc.govt.nz/non-gamebird-band-report-form If the bird is injured, please take it to the nearest Wildlife hospital   LISTEN ABOVESee omnystudio.com/listener for privacy information.

Alicia Staley is the VP of Patient Engagement at Medidata and working to bring more technology and software solutions to clinical research. With a focus on creating patient-centric clinical trials, Alicia emphasizes the value of digital tools to drive diversity of participation and retention. As a cancer survivor and patient advocate, Alicia has deep insights into how clinical trials are run and who participates.  Alicia explains, "I think the entire industry is still responding to what life looks like post-COVID. However, in particular, in clinical research, this gravitation toward more digital tools to support clinical research is still very much at the forefront. Topics like decentralized clinical trials and patient portals, patient registries, and ways to support the patient through the clinical journey using digital tools, sensors, and wearables are very much at the forefront of the conversations we're having today. Clearly there is an interest in going in that direction. And I think we learned during the pandemic that these tools are great resources for expanding the potential participation in clinical research to essentially a broader audience of participants." "It took the pandemic for the industry to realize that these tools are valuable resources. I think there had been historically quite a bit of hesitancy to embrace technical solutions like eConsent, eCOA, ePRO, or any of the eSource tools. And I think the pandemic made us realize that these tools are here, they're here to stay, and they work very, very well. But our hand was never forced in the way it was during the pandemic." #Medidata #DecentralizedTrials #Diversity #ClinicalTrials #LifeSciences #PatientExperience Medidata.com Download the transcript here

Alicia Staley is the VP of Patient Engagement at Medidata and working to bring more technology and software solutions to clinical research. With a focus on creating patient-centric clinical trials, Alicia emphasizes the value of digital tools to drive diversity of participation and retention. As a cancer survivor and patient advocate, Alicia has deep insights into how clinical trials are run and who participates.  Alicia explains, "I think the entire industry is still responding to what life looks like post-COVID. However, in particular, in clinical research, this gravitation toward more digital tools to support clinical research is still very much at the forefront. Topics like decentralized clinical trials and patient portals, patient registries, and ways to support the patient through the clinical journey using digital tools, sensors, and wearables are very much at the forefront of the conversations we're having today. Clearly there is an interest in going in that direction. And I think we learned during the pandemic that these tools are great resources for expanding the potential participation in clinical research to essentially a broader audience of participants." "It took the pandemic for the industry to realize that these tools are valuable resources. I think there had been historically quite a bit of hesitancy to embrace technical solutions like eConsent, eCOA, ePRO, or any of the eSource tools. And I think the pandemic made us realize that these tools are here, they're here to stay, and they work very, very well. But our hand was never forced in the way it was during the pandemic." #Medidata #DecentralizedTrials #Diversity #ClinicalTrials #LifeSciences #PatientExperience Medidata.com Listen to the podcast here

Our guest for this episode is a long-time REALTOR®, trainer, and world traveler. Do you have a dream to travel somewhere? Is there a place that you already love in the world? For example, have you been to Cabo San Lucas eight times? Wouldn't it be great if you could be a connector with buyers and sellers with agents in Mexico? In the Caribbean? In Europe? In Asia? You can do that with your favorite areas in the U.S. and the world! In this podcast, Ginni Field talks about selling real estate and expanding your business in new ways. We also talk about international buyers and sellers in the United States with a focus on the Certified International Property Specialist (CIPS) designation. Join us on this podcast and expand your vision beyond your local area.   [6:10] Monica asks the audience to stick with this episode to hear the interesting stories Ginni and Monica will share with consideration for the huge and growing influx of international immigrants, residents, and investors. [7:53] Ginni discusses what she learned from experiences in France, Belgium, Luxembourg, Spain, Portugal, and Germany. [11:56] When traveling the world, you have the opportunity to visit small towns and explore their history. Find people in your community from these areas and connect with them. You may be able to help them buy a home. [14:14] In most of the world, business is based so much on relationships. In America, relationships are huge and you need that network, but overseas, relationships are crucial. [15:18] In the Americas, the process of buying a home is a family affair. If they don't know you, they're not doing anything with you. When they know you and begin to trust you, business happens. [17:36] Where Ginni was teaching, there were good universities and schools everywhere, providing a place to build your business. [18:08] Find your niche and get connected to it. Be a part of those market areas and people. What businesses bring people into your market area, that hire people from other countries? [18:34] Foreign resident buyers may become citizens and still may be very connected to their foreign community. [21:42] When Ginni talks to people with work visas, they tell her they want to stay when their visa is over. Parents of foreign students in universities also will buy a home for their student in the U.S. with the hope of the student staying and the parents moving there because they own a home. [22:44] The Open Doors fact sheet says foreign students spend over $5 billion. Ginni gives estimates for several California universities. Do outreach at universities. [24:05] Look at the industries in your local community and where folks are coming from. Then begin to do outreach. Go where they are and network with them. [24:31] Refugee groups that settle in an area don't have the money to buy a house at the time, but as they become established, they work and build businesses, and become qualified to buy houses. [26:00] Ginni tells of a man who immigrated to the U.S. with next to nothing, wanting to build his life. Now, he is a millionaire, owning multiple buildings and worked hard to get there. [27:21] CIPS talks a lot about non-resident foreign buyers. These are investors buying houses more as investments than as homes. California attracts more than $1 billion in foreign direct investments from Japan, the UK, France, Canada, and Germany. [30:07] The fluctuation of exchange rates plays an important role in these investments. Fluctuations can cause a buyer to cancel. [32:14] The CIPS designation course teaches about the global market. If you're not paying attention to global opportunities, you're leaving profitable business on the table. [35:55] The world is more connected now than it ever was. Inflation is happening around the world. Pay attention to the world economy or you will miss out on tremendous opportunities. [36:33] There are investors for commercial properties, condo communities marketed internationally, college students, and refugee communities. There are many ways foreign investors purchase American real estate. [37:19] When you grow with these communities, learn about their visas and their needs, and connect them with lenders, you can help them. [38:22] Go to the HR departments of hospitals and colleges. Find out at the source how you can be a resource for their students, staff, employees, and medical professionals. [44:32] Look for international real estate conferences in a search engine and you will get a list of conferences you can attend. A list is also provided in the back of a CIPS manual. [48:11] Ginni notes that when you get your CIPS designation, you are part of a Facebook networking group. You can find an agent in the target country in minutes through the networking group [52:15] It's such a powerful thing that you can create a relationship no matter where somebody is in the world. We're all so interconnected. [52:38] Ginni's final word: “The most important thing is don't discount the global community. Don't discount the fact that the world really is a marble, that we are all so interconnected. And build that business and get the CIPS designation. It's such an important designation.   Tweetables:   “I want to share with you and your listeners the importance of global real estate, paying attention to it, and getting their Certified International Property Specialist designation. Don't miss out on opportunity!” — Ginni Field   “It's all about the relationship and trust. … When you look at the Americas, it's a family affair. The process of buying real estate is often a family affair with a hierarchy. And if they don't know you, they're not doing anything with you.” — Ginni Field   “The fluctuation of exchange rates — you have to be paying attention to that. It matters more for the investor buyer than it does for the person who's going to live in the house. ... If the exchange rate fluctuates just enough, that deal might be gone.” — Ginni Field   “When you get your CIPS designation, you‘re now part of a networking group through social media, as well.” — Ginni Field   Guest Links:   Ginni Field, REALTOR® ABR, AHWD, CIPS, CRB, C-RETS, ePro, GRI, MRP, PSA, RENE, RSPS, SFR, SRS, SRES Real Estate Trainer, Business Consultant, Risk Management Consultant, Business & Life Coach ginni@ginnifield.com www.ginnifield.com 858-774-7063   NAR Resource Links The CIPS Designation     Additional Links:   Micro courses found at Learning.REALTOR. Use the coupon code PODCAST to obtain 15% off the price of any microcourse!   Crdpodcast.com   Learning.REALTOR for NAR Online Education Training4RE.com — List of Classroom Courses from NAR and its affiliates   crd@nar.realtor   Host Information: Monica Neubauer Speaker/Podcaster/REALTOR® Monica@MonicaNeubauer.com MonicaNeubauer.com FranklinTNBlog.com   Monica's Facebook Page Facebook.com/Monica.Neubauer Instagram Instagram.com/MonicaNeubauerSpeaks   Guest Bio   Ginni Field Ginni has been in real estate since 1986, beginning her career in Fairfield, CT, and moving to San Diego, CA, and continuing her real estate career in California. Throughout most of her real estate career, Ginni served in brokerage management positions in both states with her largest office consisting of 250 agents creating profitable real estate offices in each location. Ginni has also served as Vice President of Leadership Development for an international real estate franchise sales company where she developed agent and leadership curriculum for agents and brokerage leaders. Ginni continues to write real estate training content as well as work with real estate companies as a consultant and as a coach to individual real estate agents and teams.   Achievements and Awards:   ●      REALTOR® Associate of the Year 1991 Greater Fairfield Association of REALTORS® ●      President, Greater Fairfield Association of REALTORS® 1998 ●      REALTOR® of the Year 1998, Greater Fairfield Association of REALTORS® ●      Former Director, Connecticut Association of REALTORS® ●      President, North San Diego County Association of REALTORS® 2004 ●      Former Director, California Association of REALTORS® ●      Regional Chair, Region 29, California Association of REALTORS® 2006 ●      Executive Committee, California Association of REALTORS® 2007 ●      Director, National Association of REALTORS® 2004‒2010 ●      Former Member, National Association of REALTORS® Professional Development Committee ●      Former Chair, Real Estate Business Institute Professional Development Committee ●      Member, Real Estate Business Institute Learning Experiences Committee and Strategic Thinking Committee ●      Former Director, Greater San Diego Association of REALTORS® ●      Former Director, San Diego Multiple Listing System ●      Inducted into the REBAC Hall of Fame 2013 ●      CIPS Instructor of the Year 2018 ●      Senior Real Estate Specialist Outstanding Service Award 2021

Welcome to the Photofocus Roundtable Podcast, where each month, our panel discusses some current trends and topics on our minds. Thank you Photomatix for sponsoring; click the link to download and try for free. Show Notes Nightscaper Photo Conference Storage firm Drobo has filed for Chapter 11 bankruptcy This is the new TRUST certification from the FAA for recreational flyers  For USA, start at https://faadronezone-access.faa.gov/#/ This is the study guide from the FAA for anyone who wants to use their drone commercially. Beware, it's 7 years old and some topics are out of date (night flying and operations over people, for example). PrepWare Remote Pilot app - example test questions This covers how to get a license and what you need to know in Canada to fly drones  Other regions: UK EU  YouTube Recommendations We all learn from the internet these days.  We used to say that if you want to learn something, Google it. Now, we say YouTube it. So, what is a great YouTube channel that you like to learn from? What you would recommend to our listeners?  Rob's Recommendation  Ron's Recommendation Drew  Dave About your hosts Dave Wilson Dave Wilson is a professional software engineer, occasionally-professional photographer, and recent drone convert. http://www.davewilsonphotography.com http://portfolio.davewilsonphotography.com  Instagram/Vero/Flickr: davewilsonphotography Drew Armstrong Drew Armstrong, Broker, Armstrong, Flinders & Associates Realtors PLLC ABR, GRI, CRS, CSP, ePro, CLHMS, SFR #1 Resale Real Estate Team Countywide 2000-NOW  www.UtahRealEstate.net www.drewarmstrong.com Ron Pepper is a Bay Area photographer specializing in 360° panoramic images for businesses, destinations, homes, schools and more. He's a LinkedIn Learning author, mentor and trainer. You can follow him on his website or Instagram. Rob Moroto is a commercial photographer based in Vancouver Island. From homes to people to businesses, Rob loves showing a different perspective through his lens. He sees depth in every person and every object, no matter how plain they may seem. You can follow him on his website or at CalgaryPhotos.ca.

In this episode, Oscar Gonzalez gives us a review of Outsourcing Clinical Trials New England 2022 and his fireside chat titled: "Wearables, ePRO, eConsent, Big Data: Are We Prepared for the Digital Transformation?"Oscar gives us insights into:1) Ensuring success of digital transformations2) Implementing new technologies with companies that embody the status quo3) Where the responsibility lies for delivering efficienciesThank you to our episode sponsorsLauren Perna Communicationshttp://www.laurenperna.comSigma Lab Consultinghttps://linktr.ee/sigmalabconsultingIf you are interested in sponsoring an episode or being a guest on our show, drop us a note!leanbydesign@sigmalabconsulting.comWant our thoughts on a specific topic? Looking to sponsor this podcast to continue to generate content? Reach out to leanbydesign@sigmalabconsulting.com

Editor-in-Chief Dr. Sue Yom discusses electronic patient-reported outcomes (ePROs) with Dr. Kaitlyn Lapen, a radiation oncology resident at Memorial Sloan Kettering Cancer Center who was first author of an article describing ePRO implementation in a November 2021 article, "Development and Pilot Implementation of a Remote Monitoring System for Acute Toxicity Using Electronic Patient-Reported Outcomes for Patients Undergoing Radiation Therapy for Breast Cancer"; and Dr. Patricia Holch, Reader in Applied Health Psychology from Leeds Beckett University and Dr. Galina Velikova, Professor of Psychosocial and Medical Oncology from Leeds University and the Leeds Teaching Hospital NHS Trust, who first- and last-authored an article this month describing a randomized study of ePROs versus usual care among patients receiving pelvic radiotherapy, entitled "Online Symptom Monitoring During Pelvic Radiation Therapy: Randomized Pilot Trial of the eRAPID Intervention". We review major findings from these two publications and anticipated future developments in ePROs.

ASCO: You're listening to a podcast from Cancer.Net. This cancer information website is produced by the American Society of Clinical Oncology, known as ASCO, the voice of the world's oncology professionals. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guests' statements on this podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Cancer research discussed in this podcast is ongoing, so data described here may change as research progresses. Brielle Gregory Collins: Hi, everyone. I'm Brielle Gregory Collins, a member of the Cancer.Net content team, and I'll be your host for today's Cancer.Net Podcast. Cancer.Net is the patient information website of ASCO, the American Society of Clinical Oncology. Today, we're going to be talking about what health equity and quality care mean in the context of cancer care and discuss highlights from the 2022 Quality Care Symposium in these areas. Our guests today are Dr. Fay Hlubocky and Dr. Manali Patel. Dr. Hlubocky is a licensed clinical health psychologist with an expertise in psychosocial oncology and a health care ethicist at the University of Chicago. She's also the Cancer.Net Associate Editor for Psychosocial Oncology. Thanks for joining us today, Dr. Hlubocky. Dr. Fay Hlubocky: Thank you, Brielle. Hello, everyone. So wonderful to be with you all today. Brielle Gregory Collins: Thank you so much. And Dr. Patel is an assistant professor at Stanford University in the division of oncology and a staff thoracic oncologist at the Veterans Affairs Palo Alto Health Care System. She's also the Cancer.Net Associate Editor for Health Equity. Thanks for joining us today, Dr. Patel. Dr. Manali Patel: Of course. And thanks for hosting both me and Fay to discuss this really fun topic. Brielle Gregory Collins: Of course, we're looking forward to it. Before we begin, we should mention that Dr. Hlubocky and Dr. Patel do not have any relationships to disclose related to this podcast, but you can find their full disclosure statements on Cancer.Net. So to start, Dr. Patel, can you first describe what the term health equity means and how it relates to cancer care? Dr. Patel: Great question. Nice one to start off this podcast. So I think we've always been really focused on health disparities. So I love that you've asked, what is health equity? Health equity is really reframing disparities or differences in cancer outcomes with more of a justice lens. And the full definition, which I love from the Robert Wood Johnson Foundation, describes health equity as meaning that everyone has a fair and just opportunity to be as healthy as possible. This means that you remove obstacles that may impede people's ability to attain their highest health, such as poverty, discrimination, and the consequences of such powerlessness, lack of access to good jobs, having fair pay, quality education and housing, safe environments, and health care. And as it relates to cancer care, it means that everyone has a fair and just opportunity to be as healthy as possible, even with a cancer diagnosis. This means having a fair and just opportunity to receive all of the evidence-based care that we know makes a difference, as well as high quality care that matters from screening to the end of life. Brielle Gregory Collins: Thank you so much for explaining that. And Dr. Hlubocky, talking about quality care, what does quality care mean in the context of cancer care? Dr. Hlubocky: Thank you, Brielle. So according to the Institute of Medicine, now known as the National Academy of Medicine, quality care requires the safety, the efficacy, and the efficiency of care delivery. It's also timeliness and a patient-centered approach that's coordinated by an inter-professional oncology team with the integration of evidence-based or research-based practices to continually improve cancer care. It's a very comprehensive, a very value-based form of care that adheres to evidence-based guidelines. It assures the treatment of symptoms, and the side effects of cancer, and the cancer treatment. And it's also coordinated care with strong communication amongst all clinicians and patients, which might involve a written care plan that details all of cancer care, the care in a clinical trial, if that's a potential option for patients. And it also involves shared decision-making, including honest and frank discussion about prognosis, the intensive therapy, patient's values, and also preferences regarding care. As well, it's a research-based support for psychosocial needs. It provides palliative care throughout the course of treatment from diagnosis through the end of life, and end of life care involving hospice. So quality cancer care was first coined by Dr. Joseph Simone, who was a pediatric oncologist and was the first, really, to advocate for quality-based cancer programs in pediatric oncology for both leukemia and lymphoma. And he was the one who truly started this movement that involves centering on every patient with cancer and every care program. So this year in Chicago at the Quality Care meeting, these interdisciplinary experts really highlighted the latest quality improvement research, as well as guidelines that helps us to improve the quality of cancer care from diagnosis through treatment to survivorship, and again, through end of life care. Brielle Gregory Collins: Great. Thank you so much for walking through that. And yeah, we're excited to discuss more research from the Quality Care Symposium, too, a little later in this podcast. Dr. Patel, we know that health equity and quality care are linked. So how do health equity and quality care relate to better overall cancer care? Dr. Patel: Great question. I love the fact that you brought up the Institute of Medicine's definition of quality because in my mind, doing work in health equity for over a decade now, really looking at health equity and quality, I've always thought of them as being intricately linked. But what I loved about the ASCO symposium and now some of the word choices that we're using, really does think that equity is not just a single component of quality, which previously it was. And now, the Institute of Medicine moved equity into being more of a cross-cutting dimension where it is an underpinning of all aspects of what Fay just outlined, in terms of effectiveness, safety, timeliness of care, etc. I think equity, in order to actually achieve high quality care, especially in the cancer realm, health equity has to be a fundamental component of such care. And so now, I'm going to take a step back because I think for years, we've been looking at equity as more of an issue of just access. But you heard in Fay's definition, and the definitions that are out there, that exist for quality, that equity and quality are not really just about access. In other words, differences in cancer care and inequity in cancer care is due to the fact that some populations, such as racial and ethnic minorities, for example, have poorer access to care than others. That is true, but this is just one factor, and it's not the only factor. Even when access is equal, we know that some populations tend to receive lower quality cancer care than others, be it by race and ethnicity, be it by socioeconomic status, gender identity and sexual orientation, or even age. So really, equal access does not equate to equitable care. What's nice about linking quality and equity and this intricate linkage of the 2 means that you're addressing the effectiveness of the care. You're ensuring that, when you think of quality in terms of equity, the outcomes you're thinking about in terms of race and ethnicity and actually moving towards considering, for example, what different things mean to different patients in terms of effectiveness, safety, timeliness of care, and ensuring that not only are people receiving the care, but that they're all receiving high quality care. I hope that makes sense. Brielle Gregory Collins: It absolutely does, and I appreciate you, again, walking through that and just explaining how those 2 are connected. And I want to go into some of the research that was presented at this year's Quality Care Symposium. So Dr. Hlubocky, can you introduce some of the key studies or themes that came out of this year's symposium that addressed quality care? Dr. Hlubocky: Thank you. Absolutely. There were several key quality cancer care themes that had to illuminate the cutting-edge research that is being conducted today and the advances by noted experts in the field, specifically at the symposium. The first being financial toxicity, or financial hardship, and problems that patients may encounter that's caused by the cost of treatment. This was identified as a major thematic session, where multidimensional approaches to addressing financial toxicity were presented, things like screening interventions, survivorship advocacy, and policy. Additional interventions to address financial toxicity were presented. And Dr. Ezekiel Emanuel, from the University of Penn, he's Vice Chair of Global Affairs, but a well-known ethicist in the country. He actually launched the meeting with a phenomenal keynote that was entitled, “New Directions for Cancer Care in the U.S.: Building a Transformational Research and Development Ecosystem and Healthy Payment Landscape That Better Supports Our Patients.” We then heard about how screening tools add value to identify patients with financial hardship and how to best implement them. We learned what other cancer centers have implemented regarding financial toxicity programs, and how any cancer center or any practice can implement these tools and interventions aimed at helping our patients with financial toxicity or hardship. Additionally, smart solutions like leveraging digital health tools to improve cancer care delivery, this also included a study on how health technology can be utilized to improve the delivery of cancer care today and the future, which evaluated the use of web versus mobile devices for ePRO reporting [electronic patient-reported outcomes reporting] and severe symptom responses. I believe it was 6 cancer centers. Symptom monitoring and what we refer to as patient-reported outcomes was also a key topic. And we heard about severe symptom reporting in medical oncology patients at a community center that was assessed through a platform, as well as severe symptom reporting and surgical patients assessed through an EHR-integrated ePRO questionnaire, again, at 6 centers by Dr. Wong at Dartmouth. Physical impairment, pain, and fatigue were top concerns that were identified, and Dr. Wong and her team also identified predictors of severe symptoms so that population surveillance should be considered a priority. And she also encouraged that interventions are really needed to address common severe symptoms and that these future studies should define what is the most effective migration strategies for these symptoms. Successful integration of health care and health services research interventions in oncology was also another thematic session, and it offered a framework for leveraging health care services research to improve cancer care delivery across the diverse populations. And we know that leaders in the field discussed a variety of these interventions, including hospital at home and geriatric assessment. For example, guidance and geriatric assessment and clinical practice was also presented by the former Cancer.Net geriatrics editor, Dr. William Dale, which included a need to use to inform treatment decisions which would systematically change cancer care delivery. And finally, an interactive roundtable on rethinking advanced care planning was also held here. These panel experts examined the current model of advanced care planning. What is the merits? How can it be reimagined? And how do we measure outcomes and tools, and what is the impact on caregivers? And finally, regarding the smart solutions, leveraging the digital health tools, we looked at big-tech solutions to common care delivery obstacles, leveraging electronic health records to support treatment and achieving equitable screening. Especially, for example, lung cancer was discussed. I think that hit most of the studies that were presented. What do you think, Manali? Did I miss anything? Dr. Patel: You did a really nice job of highlighting all of them. There were so many exciting studies that were presented, and it was really a fun meeting not only to spend time with you, Fay, but then also to meet up with colleagues and to see the cross-cutting research across both equity and quality, and the linkage between the 2. On that note, I think I can talk about the different ones that were kind of more focused on equity. And the opening theme was a really nice theme about the structural barriers to equitable care delivery. And again, when you think about quality and equity as being intricately linked, if people are unable to get the highest evidence-based care, providing care-- we can provide care, but if it's not evidence-based care, then are you really moving the quality needle forward? And so the opening theme really looked at, I think, reframing and shifting our views of the focus on the patient as the reason for disparities and inequities to really thinking about structural barriers and barriers that may exist not only at the policy level, but also barriers that exist just in the way that our system is set up with structural racism, ways to overcome structural racism through system-level changes. Another theme that I thought was really nice that was highlighted was the impact of social determinants and complications from social determinants of health on being able to achieve the highest quality of cancer care for patient populations. And a lot of studies looked at associations of the impact of housing and other health-related social needs such as transportation aspects, which we all know are a clear indicator and a clear barrier for some in terms of being able to achieve the highest quality care. We also saw a lot of abstracts both in the poster discussion, as well as in the main plenary session, including Dr. Otis Brawley's presentation that talked about this very question really here that you're asking us, which is about the linkage between quality and equity. And that entire plenary session that I would love for others to go back and to listen to had some very key poignant takeaways about the linkage, and how that has changed and morphed over time, and also, how our view of equity and this intricate linkage-- again, I know I keep saying intricate linkage, but that's because that's what it is. But this component being more of an underpinning, looking at quality from a whole, from the lens of equity, he did a really nice job of shedding light on this topic. Brielle Gregory Collins: And Dr. Patel, I do want to ask one follow-up question. So you mentioned this term, social determinants of health. Can you just briefly describe for our audience what that term means? Dr. Patel: Yeah, very good question. And I think there's a lot being done at ASCO, but also at the national level. And the social determinants of health are these structures that are set up within the way that our social system is set up. So things like housing, transportation, food. Interpersonal violence, for example, is one kind of health-related social need that can come out of not having access. But these are the social structures that are set up that determine how healthy you can be. So if you take a step back and you think about cancer care, for example, and you look at individuals that may not have a home and may have homelessness, and you think about how our treatments may impact. So many of our treatments may cause people's white blood counts to lower during periods of their treatment where we hope they aren't living in congregated areas such as homeless shelters, for example, where they can then become really infected with what we call opportunistic or other infections during treatment. How the homelessness situation impacts someone's health. We know that it not only impacts their ability to receive and our ability, as clinicians, to provide the highest evidence care for individuals living in those situations, but it also impacts other health. And we know that homelessness really does impact an ability for one to be able to be as healthy as possible. The same with food. We know that the pandemic and some of the work that we've done, Fay and I together, as well as others, have looked at the impact of the pandemic on food insecurity. Now, food insecurity has been a large issue for people, and a determinant of health is what I call it, a social determinant of health. But we know that food is medicine, and for people during the pandemic, we saw food insecurity significantly rise due to wage loss, due to other issues regarding income loss. And that then led to being unable to be able to eat as healthily as possible. If you don't have access to the right food, we know that that makes a difference in terms of your ability to make it through particular cancer treatments. For example, if you're unable to get enough magnesium, calcium, potassium, that can influence what we call your electrolytes and your labs, and make it very difficult for us to give treatment. But even prior to a cancer diagnosis, we know that food determines how healthy you are. And if you're unable to attain food sustenance even from an early age, that can really lower your ability - if you go back to the definition of health equity - your ability to be as healthy as possible. And these social structures then, which I loved about the ASCO Meeting this year, is-- I've been going to the ASCO Quality Meeting for many years and have kind of been-- Fay knows, right? We've kind of been like these lone people out in our little group of people that come to the ASCO Meeting and the Quality Meeting. We all speak the same language, but there was a real emphasis on interventions this time around, and how can you overcome what, traditionally in the medical realm, we don't think of as being linked with health or at least in oncology? I think primary care physicians and pediatricians have been focused on this for many years. But for us, in oncology, it hasn't really been first and foremost as part of our problem that as oncologists, if we know that people cannot get to our clinic, we need to intervene on transportation. But these other issues like homelessness and food insecurity and poverty really are also in our realm as well in terms of impacting one's ability to achieve health equity. Brielle Gregory Collins: Thank you so much. That's a really helpful explanation. And too, I want to get into-- there was all this great research to come out of quality, but I want to talk a little bit about what changes are happening in cancer care to improve health equity and quality care. So Dr. Hlubocky, we can start with you. Can you talk a little bit about some of the changes you're seeing happening in cancer care to improve health equity and quality care? Dr. Hlubocky: Well, I love what Manali has said about coming together first as a community at the meeting, where we're not just friends and colleagues, but we're collaborators and mentors to one another, and we are stimulated by one another's presentations to truly design research that optimizes care for every patient everywhere. And I think that's now the priority in that. And it's important to learn about some of the best practices that can help clinicians really reshape strategies and make key decisions to improve, as we said, that quality, that safety, and the efficiency of cancer care delivery. Certainly at ASCO, we're doing quite a bit with the QOPI Initiatives, the Quality Practice Initiatives, where every cancer center or practice has access to measures that are evidence-based, so we can identify what are the key symptom issues that patients are experiencing so we can use these measures. And ASCO has really been a wonderful partner for many practices along the way. So it's really, really seeing this research is such a motivator. And I wonder, Manali, what additional highlights stick in your mind as to what is the future when it comes to cancer care? Dr. Patel: Yeah. I mean, that's a fantastic question. I love this question, Brielle, that you're asking us to reflect on. As I mentioned, I really do think that there's been a real shift. And sadly, I think it took George Floyd's murder to link us to the huge discourse. Now that's happening not only in our own small circles locally, but also at the national and policy level, that equity, more so than I've ever seen at a meeting, even at our annual meetings in ASCO, has really become the forefront. And I've started to see meaningful change of not just talking about equity, but also thinking about interventions. I certainly, we think that we're seeing more discussion about equity, more awareness of the importance of equity. The question that you just asked about social determinants of health now is now part of our vernacular and our lingo now, which is wonderful, that we don't always have to describe the impact that social structures and our systems set up for us to be either healthy or not. But what we're also seeing are more dollars being put into incorporating equity, not just research dollars. I think what we saw at the ASCO Quality Meeting was there's a lot of research in this area and there are a lot of like-minded folks that are collaborating together to try to overcome this. But there are also programmatic dollars. And I think even within ASCO and within other organizations that are traditionally medically focused, there's a highlight of equity as part of the mission statement now, which is hugely different than where we were just a couple of years ago when both Fay and I were on the Health Equity Committee, that was not part of the mission statement. So the fact that that's being applied in a visual statement is really different. We're also seeing policies being made both at the local level. For example, in California, lots of policies being made for MediCal organization.  We're starting to see more of a reflection of inequities in care and really, interventions to try to move that on the ground, both within clinics reporting on data, like Fay mentioned, I think is extremely important. A basic step, yes, but one that just has not-- it's been lacking. We conducted a project that was led by Lori Pierce and others through ASCO that looked at just who are the people that are coming into your center? And how many are being enrolled on clinical trials? And what are the race and ethnicity and income and social status of these individuals? And many centers just are unable to report that because we don't collect data on it. So Fay mentioned that something that does seem very basic now is becoming part of the fabric and there's now more understanding as to why these things are important, and why we need to measure them. And what are we going to do about it? So I really like that there's research happening in parallel where, again, as I mentioned, there were a lot of abstracts that were focused on the association of housing. But at the same time, then you've got interventions that address housing. People that are working with housing authority, or even at the VA, for example, creating safe housing for people during treatment. It doesn't address the whole issue of homelessness, but it does try to band-aid the situation until we have national policy that can provide better housing for individuals overall, or to address some of these issues. And I think that it's been really refreshing-- I don't know about you, Fay, but just for me, refreshing to see interventions that are solution-focused. And what can we take away from these abstracts and really try to implement at home? Or what are some novel ideas that we can do to overcome some of these issues? I hate being stuck in the description paradox of disparities, disparities, inequity, but no real solution as to what we can try to do at home. Dr. Hlubocky: I fully 100% agree with Manali's statement right there. Brielle Gregory Collins: Absolutely. And it's so exciting to hear about improvements being made and the needle being moved forward in these areas. I'm sure it's very reassuring for patients to hear that. And speaking of that, there's so much information in this area. For both of you, where do you recommend patients can go online to learn a little bit more about health equity and quality care? Dr. Hlubocky: Yeah. First and foremost, Cancer.Net. Of course, we have such wonderful content associated with many of the topics that we discussed today, such as financial toxicity, and various symptoms, and psychosocial issues, depression, anxiety, palliative care, end-of-life care. So that's definitely the first stop. As well as the American Cancer Society would be the next one. And the National Coalition for Cancer Survivorship. And of course, the National Cancer Institute, which centers-- they all center on quality care issues, such as those we just discussed today. And of course, I don't know about you, Manali, but really talking also to your cancer team. So that's the first step. But really, I think so many patients are fearful to address some of these issues with the team, [and think that] that we don't have time, and we make time. We make time. Our patients are very important to us, and we really want to optimize care the best that you can. So if any of these issues are a burden and barriers to getting the best care, please reach out to us. There are financial navigators, there's palliative care clinicians, psychosocial clinicians, and many cancer centers, as well as some practices in that. So talking to your oncologist, talking to your nurse practitioner, and they are great resources as the first step to attaining care after you've read some of these resources. Are there others that come to your mind, Manali? Dr. Patel: Yeah. I mean, great question. I love how you brought it back to the local teams. In terms of thinking about resources, I agree, there are a lot of resources that are local. And so ask your clinical teams, but then also other patient advocacy groups may have more information about resources to overcome some of the barriers that some patients are having, particular barriers, just to get general information about health equity. As Fay mentioned, we love Cancer.Net. I mean, I think it's one of the best resources that I've seen. In fact, my mother and my father go to the website pretty often. They are both cancer survivors as well. But there's a nice piece, again, about health equity and how it integrates into all facets of care and all facets of one's journey through cancer. I think, as I mentioned before, the Robert Wood Johnson Foundation really has nice resources on health equity and also other web-based portals that you can delve into. So there's as much information as you want to learn about health equity, and also solutions focused more on the general picture that's maybe not related to cancer, but again, is linked to cancer. The American Public Health Association is also another really nice website that has a broad swath of how health equity and the issues that we talked about today, the social and economic structures, impact one's health overall. Again, not cancer-related, but everything is cancer-related. And so you can bring back some of those take-home messages to how it may impact one's cancer care. And then I really love-- for me, personally, the University of California Berkeley is a nice, free resource that has publications, depending on how deeply you want to delve into the questions and some of the brief topics that we've talked here, that are all focused on health equity. And it's a really nice website that hopefully, we can put into the link of the podcast description. Brielle Gregory Collins: Absolutely. Those are great resources. Thank you both for sharing those. And thank you again for your time and for sharing your expertise today. This was such a great discussion. It was really great having you both. Dr. Patel: Well, thank you for even highlighting this important topic of health equity and quality. Again, for me, it seems just completely, almost a no-brainer, that these 2 go together. But it's not always as easy as you think to link the 2. And so it's really nice that you all have come up with this podcast idea and also brought wonderful Fay and me together to do this. [laughter] There's so much admiration for what Fay is doing, and it was really humbling to be on a podcast with you, Fay. Dr. Hlubocky: Oh, it's an honor and a pleasure to be with you, Manali. You truly are an advocate and a guru, a wisdom when it comes to equity and equity issues and illuminating the issues nationally. So such an honor and pleasure to be with you. And of course, with Claire and Brielle, and to all the patients and caregivers and our colleagues, we're here for you. So don't forget to reach out to your oncology team and here with us at Cancer.Net. Brielle Gregory Collins: Thank you both so much. ASCO: Cancer.Net Podcasts feature trusted, timely, and compassionate information for people with cancer, survivors, and their families and loved ones. Subscribe wherever you listen to podcasts for expert information and tips on coping with cancer, recaps of the latest research advances, and thoughtful discussions on cancer care. And check out other ASCO Podcasts to hear the latest interviews and insights from thought leaders, innovators, experts, and pioneers in oncology. Cancer.Net is supported by Conquer Cancer, the ASCO Foundation, which funds lifesaving research for every type of cancer, helping people with cancer everywhere. To help fund Cancer.Net and programs like it, donate at CONQUER.ORG/Donate.

Dr. Cardinale Smith, of the Mt. Sinai Health System, and Dr. Stephanie Wheeler, of the UNC Lineberger Comprehensive Cancer Center, discuss key research featured at the 2022 ASCO Quality Care Symposium, including practical solutions to advance equity, new trends in cancer care delivery, and novel approaches in palliative and supportive care.   TRANSCRIPT Dr. Cardinale Smith: Welcome to the ASCO Daily News podcast. I'm Dr. Cardinale Smith, a professor in the division of Hematology and Medical Oncology and Department of Geriatrics and Palliative Medicine at the Icahn School of Medicine at Mount Sinai in New York, and the chair-elect of the 2022 ASCO Quality Care Symposium. I'm your guest host today and delighted to welcome the chair of the Symposium, Dr. Stephanie Wheeler. Dr. Wheeler is a professor in the Department of Health Policy and Management and associate director of Community Outreach and Engagement at the University of North Carolina Leinberger Comprehensive Cancer Center. We'll be discussing practical solutions and key research to advance equity and quality in cancer care, new trends in cancer care in the home and local community, novel approaches in palliative and supportive care, and other key takeaways from the meeting. Our full disclosures are available in the transcript of this episode, and disclosures relating to all episodes of the ASCO Daily News podcast are available on our transcripts at: asco.org/podcasts. Dr. Wheeler, it's great to be speaking with you today. Dr. Stephanie Wheeler: Thank you, Dr. Smith. I'm excited to be here. Dr. Cardinale Smith: Well, I'm super excited that I just got to see you, and it was fantastic that we had a hybrid event that really allowed our participants to meet in person and allowed folks who couldn't be in person to participate virtually. Cancer health equity was a major theme this year with sessions that explored how to incorporate equity into our work. Can you highlight a few takeaways for us? Dr. Stephanie Wheeler: Absolutely. And yes, it was such a delight to see you in person. And I'll just note that at this 10th anniversary of the Quality Care Symposium, we had record attendance - over 700 participants. So, I was really excited to have that level of engagement in this meeting. So, you know that as a planning committee, we really prioritized centering equity in our content this year, and I think it was reflected in every session at the meeting. Our very first educational session featured Drs. Chanita Hughes Halbert, Meera Vimala Ragavan, Victoria Blinder, and Sam Cykert, as well as community advocate, Terrence Muhammad, from the Greensboro Health Disparities Collaborative. Together, they provided important foundational and conceptual context to really set the stage for the rest of the meeting. Most importantly, they discussed specific evidence-based interventions designed to improve racial, socioeconomic, and rural health equity. These included the Accure Realtime Health Alerts Intervention with Navigation and Bias Training and Financial Hardship screening. Later in the meeting, we heard from Dr. Joannie Ivory presenting Abstract 68, who shared that we really need to take our trials where minoritized and historically disadvantaged populations live. In that study, geographic areas with greater numbers of black residents did a better job recruiting black participants to clinical trials, and the trial itself built in structural factors designed to ensure that at least 30% black participants were accrued. I also want to shine a light on the wonderful abstracts that were presented by Drs. Qasim Hussaini and Qinjin Fan, Abstract 69 and 3, which focused on association between historical housing discrimination and modern-day mortgage discrimination in colon and lung cancer treatments and outcomes respectively. I think this work just further underscores that racism is structural and societal and that we need to be paying attention to not only how we deliver oncology care, but policy in the banking world, the housing world, education, transportation infrastructure, and so much more, if we're serious about undoing disparities in cancer. Dr. Cardinale Smith: Yeah, and I'm probably biased since I had a role in planning this meeting. I definitely appreciate the focus on not just calling out these issues, but really thinking about how we start implementing interventions to really overcome them. Thank you for that really wonderful summary. The symposium also featured many trends in quality care, such as patient-reported outcomes measurement to monitor quality and patients' experiences. What are the sessions and abstracts that you think will give our listeners new ideas about how to integrate patient-reported outcomes into real-world settings? Dr. Stephanie Wheeler: Well, as you know, this continues to be an ongoing theme of the ASCO Quality Symposium. And I was really particularly encouraged this year that the focus was on implementation of PRO monitoring in real-world settings. So, just to highlight a few of the sessions that stood out to me were, dual abstracts 243 and 242 that were presented by Drs. Sandra Wong and Jessica Bian, showing symptom-reporting implementation in the medical oncology space, as well as the surgical oncology space, participating in the eSyM study at multiple cancer centers. In addition, we had an educational session that followed in which Drs. William Dale, Manali Patel and Sarah Hawley, presented work describing their efforts to implement geriatric assessment, multimodal symptom-control monitoring interventions in racially diverse populations, and a prostate cancer symptom-focused self-management intervention respectively. Then towards the end of the meeting, we also heard from Mike Hassett, presenting Abstract 241, who talked about differences in web versus mobile devices for ePRO reporting, and how those can really elicit different types of symptoms that are reported by different types of patients. We know that the digital divide is real in America, and so as we think about how to get patients to report their symptoms in meaningful, actionable ways in real-time, we have to be mindful of the modalities in which we're eliciting those symptoms. So, it's clear to me that the discussion has really moved beyond why we need to monitor patient-reported outcomes. I think Ethan Basch's work and others has really demonstrated that clearly to how best we can optimize it for patients' benefits while working within the constraints of existing EHRs and workflows, and of course, the constraints of our Wi-Fi connectivity in rural communities. Let me ask you a question. How about that? So, the palliative care abstract track was a new feature this year, and I was really excited about it. And I'd really love to know from your perspective as a specialist in Geriatrics and Palliative Medicine, how do new approaches that are going to be important in oncology best meet the needs of our patients? And how did this year's session content advance that field directly? Dr. Cardinale Smith: In addition to the implementation of patient-reported outcomes, which you spoke about, which I think is really incredibly critical, especially because we know that the data suggests that that's also associated with not only improvement of quality of life, but also survival. I was really excited to help moderate a session along with Dr. Shanthi Sivendran on the panel focused around advanced care planning, and really thinking about, "Is it time for a change?" And so, on that panel with us, were experts leading advanced care planning, Drs. Alcorn, Hickman, Montgomery, Paladino, and Rhodes. And really the topic of the conversation centered on changing the frame of thinking away from focusing just on documentation, but more about the conversation itself, and the focus on goal-concordant care, and how do we align goals and values with the cares received, and how do we talk about that? We also talked about how we align that with measurement. So, as we move towards value-based care in Oncology, how do we have better outcome measurements to capture impact? Like recently approved measures in the palliative care space of being seen and heard that was discussed. And shifting gears a little bit, we heard in an oral abstract presentation number 300 by Dr. Riaz, talking about outcomes of hospitalized patients with solid cancers receiving immunotherapy. We know that that is a group who are often receiving treatment closer to the end of their life in the hospital setting, and we don't have lots of data about how successful those treatments are. And what that data demonstrated among 159 patients over four academic medical centers, is that about approximately 30% of them who received inpatient immunotherapy actually died in the hospital. And so, I think that has really important implications as we think about the quality of life for these patients, as we also think about those quality metrics that we have to be adherent to. Continuing to think about how that impacts financial stressors for patients. You know, financial toxicity is a recurring theme at many of our ASCO meetings, and at this Quality meeting, we had a session that featured a multi-layered approach to financial toxicity solutions. Can you tell us about some of the key features of this approach? Dr. Stephanie Wheeler: Of course. Yeah. This was a wonderful session. I just have to note that the session on advanced care planning, one of the things that I really loved about that, before I talk about financial toxicity, was that the roundtable focus of that session, that particular modality, I think, just lent itself so well to the type of discussion that we were having, and it just felt very interactive. We had lots of great input from the audience, and I've continued to hear, since the meeting, that people really appreciated that. And I have to attribute your leadership there to thinking carefully about how to do that session. So, we should think about that more in the future as well. Turning to financial toxicity, this, like equity, I think, was a recurring theme of this meeting. And in particular, I think the poster sessions also covered a lot of content in the financial hardship space. So, you mentioned the educational session focused on multi-layered approaches to solutions here. And this session featured new work from folks like Dr. Maria Pisu, Samilia Obeng-Gyasi, and Emeline Aviki, and they were all talking about interventions in their cancer centers that were focused on timely identification of financial hardship, and different ways in which it can be screened for and that it can be actionably responded to. And then, Dr. Aviki described approaches that their center has used to really develop a multidisciplinary financial working group to address concerns. And I thought that was really creative and showed that all of the right stakeholders were at the table at Memorial Sloan Kettering. And then that session finished with remarks by Joanna Morales about the legal parameters of financial hardship, which I think are increasingly being understood as a really important determinant of poor outcomes. And we all know the legal system is incredibly difficult to navigate for people who don't have a legal background, and I love that she described some of the actionable ways in which people can do things like: better understand their employment protections, better advocate for themselves to be sure that their workplace accommodations are being responded to, and also thinking about their ability to advocate more for themselves when it comes to things like social security, disability insurance applications, and the legal parameters there. She also talked about policy options, and so I think this is a must-listen-to session for anybody who's interested in thinking about screening for and developing institution-wide efforts to address financial hardship through identification, and through legal approaches and levers that can mitigate and hopefully prevent it. By next year, I think it's important that we know that there are at least five NCI-funded clinical trials underway that are testing additional navigation and insurance literacy interventions in multi-sites across the country. And so, I think it'll be really important to see what happens with those studies as they move forward. And there is an NCI-supported financial hardship session and workshop that is happening later this week that Dr. Janet De Moor invited all ASCO Quality attendees to come to. So, more on this, I think in the future, but I don't see this as a topic that will be left off the agenda for the ASCO Quality Symposium for many years to come. Dr. Cardinale Smith: Yeah, and hopefully we'll be able to have some of that data presented at the next meeting next year. And just following up on that theme of financial burdens for our patients, I really would like to encourage anyone who didn't get a chance to hear this year's keynote lecture from Dr. Ezekiel Emanuel of The University of Pennsylvania, to really take some time and go take a listen to it. Dr. Emanuel focused on payment structure and models and had several key takeaways that I thought were really important. His main conclusions were that we need to think through new policies related to drug pricing and accelerated approval, as these have really important implications for the cost of cancer care. He also talked about how oncologists and those of us in the cancer care space and cancer care delivery space, have an increasing role to sort of nudge the NIH to think about their role in the research and development process for drugs, and to boost clinical trial enrollment. Specifically thinking about the enrollment of minoritized populations. And then lastly, and probably most provocative, which is one of the reasons why we really wanted him to come and to speak at this meeting, is that we know financial toxicity is significant and needs to be addressed. And he proposed that once a person is diagnosed with cancer, insurance companies, Medicare, should eliminate any deductibles, co-payments, or co-insurance, and other types of cost-sharing for our cancer patients, which I think is an interesting viewpoint. Dr. Stephanie Wheeler: Yeah, I couldn't agree more. And as a health policy scholar, I was sort of jumping in my seat with excitement over some of the bold and innovative solutions that he put forward. I think another compelling speaker, and I know you'll agree with me, is Dr. Otis Brawley. He's the Bloomberg Distinguished Professor of Oncology and Epidemiology at Johns Hopkins University, and he was honored with the Joseph Simone Quality Care Award, which of course, is focused on, really, lifetime achievements in the areas of quality care delivery in cancer. He's been such a champion of cancer care equity, and really has devoted his whole career to advancing cancer prevention, screening, and treatment strategies, to end the racial, socioeconomic, and rural disparities that we see in prevention, detection, and treatment of cancer. One of the things that he really emphasized that I appreciated is that we have to be more thoughtful about the ways in which we think about cancer health disparities, recognizing that more treatment is not always good treatment, and the more money that we spend on futile treatments and unnecessary treatments, and unnecessary care, that actually wastes resources that we could have otherwise distributed more fairly to our marginalized and minoritized populations. And so, he made a very direct argument between overspending, overdiagnosis, and overtreatment in cancer, and how that actually contributes to disparities in care, and disparities in outcomes. And I think that that really motivates us to not only look at the national movements in health policy reforms as important to do from an efficiency perspective and from a cost-control perspective because we know that healthcare costs in America are wildly out of sync with the rest of the world and unsustainable, but also because they're a key contributor to differences and outcomes that we see, and that we have a moral imperative to address. So, I was just really inspired by his talk. He covered so much territory in a small amount of time, and I think his talk in particular, combined with Dr. Emanuel's talk, really set the stage for us to think about the integration of policy, and equity, and care delivery together as we move forward in this field. Dr. Cardinale Smith: Yeah, I am definitely a fan, and I think to highlight both of them, there are tangible things that we can all walk away in our everyday lives and start putting into practice, which I think is key for us to move the needle on any of these things. Dr. Stephanie Wheeler: Yes. And I might say just in response to that, that towards the end of the session, we had that great oral abstract session that Melissa Simon and Blase Polite were the discussants for, and they really continued this theme of not just really unpacking these deeply-rooted social and historical root determinants of differences in outcomes, differences in quality, and problematic equity issues in cancer care delivery. But I think that they also gave us a number of things, as you said, that each of us can do in a more meaningful way on a daily basis. You know, being more aware, promoting others, sponsoring others from different backgrounds, really standing aside and allowing others to shine, and that has been a theme of this meeting. It's something that we wrote about last year, that this meeting is a place where junior scholars and trainees can come and connect and can really find not only a place here but can find a stage here. And so, I think some of the comments that they encouraged us to think about were specifically related to professional development and lifting up others, and paying it forward, and it resonated with me, in addition to the many other things they suggested around just how our healthcare systems are designed, and how we need to break down barriers. Dr. Cardinale Smith: Well said. I could not have said it any better. Thank you, Dr. Wheeler, for coming on the podcast to give us these highlights from the 2022 ASCO Quality Care Symposium. Our listeners can find the links to the abstracts we've discussed on the transcript of this episode. Dr. Stephanie Wheeler: Thank you, Dr. Smith. It's my pleasure to be here with you today and to have co-hosted this planning committee and this meeting with you, and I am so thrilled for your leadership next year as you take the gavel, take the stage, and lead us forward. Dr. Cardinale Smith: I can't wait to get started. And to you, our listeners, thank you for your time today. If you value the insights that you hear on the ASCO Daily News podcast, please take a moment to rate, review, and subscribe wherever you get your podcast. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy, should not be construed as an ASCO endorsement. Follow today's speakers: Dr. Cardinale Smith @cardismith  Dr. Stephanie Wheeler @StephWheelerUNC Want more related content? Listen to our podcasts on interventions to address financial toxicity. A Novel Approach to Address Financial Toxicity Dr. Derek Raghavan Has a Remedy to Mitigate Financial Toxicity in Cancer Treatment Follow ASCO on social media: @ASCO on Twitter ASCO on Facebook ASCO on LinkedIn Disclosures: Dr. Stephanie Wheeler: Research Funding (institution): Pfizer Foundation Travel, Accommodations, Expenses: Pfizer Dr. Cardinale Smith: None to disclose

Společnost ČEPRO a.s. je největší skladovatel pohonných hmot v ČR a také jejich distributor, prodejce a majitel sítě čerpacích stanic EuroOil. Je to akciová společnost vlastněná ze 100% státem. S předsedou představenstva Janem Duspěvou jsme mluvili hlavně o současných cenách benzinu, ale také o konci povinného přimíchávání biosložky do pohonných hmot nebo o rizicích spojených s válkou na Ukrajině.

Sam and Ivanna speak to Willie Muehlhausen about how simplifying and automating patient reported outcomes is not so much complicated, as it is complex. Willie shares his perspectives on the evolution of ePRO and eCOA and how the newer trend of decentralised clinical trials is closely tied to mastering the collection of patient reported outcomes. Willie is working towards making it possible to translate a clinical protocol into configuration in 12 minutes instead of 12 weeks and hints at other possibilities yet to be explored . If Willie could change one thing in our industry it would be increasing the level of knowledge sharing and knowledge retention. “The purpose is to get good data while making it easy for patients”  Willie Muehlhausen  Notes & LinksGuest Willie MuehlhauseneCOA Consortium (formerly known as the ePRO consortium) Safira Clinical Research Limited Recall Bias CDISCODM XML Guidance on Ecological Momentary AssessmentConsidering BYOD in Clinical Trials eConsentBooks by Willie MuehlhausenPatient Reported OutcomesElectronic Patient-Reported Outcome Measures: An Implementation Handbook for Clinical ResearchTechnology mentionedeProeDiaryeCOAAI/ MLEHREDCPDAsFunctions mentionedCROs Clinical Sites SponsorsData ManagementStatistical Programming Abbreviations & DefinitionsAI: Artificial IntelligenceAPI: Application Programming Interface BYOD: Bring Your Own Device BYOT: Bring Your Own Technology CDISC: Clinical Data International Standards ConsortiumCRA: Clinical Research Associate DCT: Decentralized Clinical TrialEDC: Electronic Data CaptureeDiary: Electronic DiaryEHR: Electronic Health RecordsePRO: Electronic Patient Recorded OutcomesEMAs: Ecological Momentary Assessment FDA: Food and Drug Administration JSON: JavaScript Object NotationML: Machine LearningODM-XML: is a vendor-neutral, platform-independent format for exchanging and archiving clinical and translational research dataPDA: Personal Digital Assistant 

Společnost ČEPRO a.s. je největší skladovatel pohonných hmot v ČR a také jejich distributor, prodejce a majitel sítě čerpacích stanic EuroOil. Je to akciová společnost vlastněná ze 100% státem. S předsedou představenstva Janem Duspěvou jsme mluvili hlavně o současných cenách benzinu, ale také o konci povinného přimíchávání biosložky do pohonných hmot nebo o rizicích spojených s válkou na Ukrajině.

Nová nízkoemisní nafta a palivo s bezemisním certifikátem o úspoře CO2. Čepro se připravuje na „zelenou éru“ a na pumpách nabídne nové produkty. Státu letos firma pošle rekordní dividendu.Čepro budoucnosti? Bude nabízet vodík, elektřinu z obnovitelných zdrojů a dál strategické komodity skladovat pro stát. Klasická paliva, tedy benzin a nafta, však budou v nabídce ještě hodně dlouho. „Věřím, že ještě mnoho let budeme poskytovat servis v nabídce fosilních paliv, tak, jak jsme zvyklí. Věřím, že to budou desítky let, “ říká v rozhovoru pro Agendu SZ Byznys předseda představenstva Čepro Jan Duspěva.Firma se už ale na novou éru chystá. Aktuálně začne na svých čerpacích stanicích nabízet novou „ekologickou“ naftu s příměsí HVO a paliva z bezemisním certifikátem.I samotné čerpací stanice už prochází proměnou a mění se na místo obecného obchodu. „Dnes se hodně čerpací stanice zaměřují na další služby. Vydávání balíků, poštovní služby, hodně nahoru jde bistro,“ říká Duspěva. Čepro chystá také své první dvě vodíkové stanice. Do dvou let mají vyrůst v Zelenči u Prahy a Cerekvicích. Agenda. Rozhovory s top lídry českého byznysu, zakladateli firem, odborníky. Čtvrthodinka o byznysu z první ruky. Každý všední den na SZ Byznys a ve všech podcastových aplikacích. Odebírejte na Podcasty.cz, Apple Podcasts nebo Spotify.

Patients and care teams benefit from electronic, patient-reported outcomes. John Elliott, vice president of sales at Carevive, and Rami Elsabeh, chief product officer at DTX, spoke with Oncology and Technology to stress the importance ePROs play across patient populations. DTX is a web-based ePRO tool that uses automated SMS surveys to connect with patients throughout their care episode. Elsabeh said this software allows for streamlined information exchange between patients and the care team. “ePROs historically have been predominantly used more in a research capacity,” Elliott said. “That was the original case for ePROs, and it was fairly removed from any type of reimbursement. What's really evolved is when you have major payers, and you have CMS, and you start looking at value-based reimbursement models, there is strong advocacy for ePROs.” Because ePROs were primarily a research tool, the original focus was data collection. “Nowadays, with the increase in value-based care, reimbursement being tied more and more to quality of care versus quantity of care, and the emphasis on patient outcomes and cost-reduction methods, the ePRO systems they need to have extended capabilities,” Elsabeh said. “What's huge about the evolution is the integration capabilities now,” Elliott said. “So, taking it from a fairly segmented, siloed, single research population to a standard of care for a much broader patient population with actionable capabilities for the care team. That's how you get to the improved outcomes.”

Patients utilizing Carevive's PROmpt engagement tool and ePRO systems now have an assistant they can rely on to help them. Meet CLARA, Carvive's Longitudinal Assessments, and Reporting Assistant. SarahLena Keckler, Director of Product Management at Carevive, and Nadia Still, Carevive's Senior Director of Client Success, walked Oncology and Technology's James Kent through how CLARA came about and how this virtual assistant will make a big difference in patient-reported outcomes. Studies show numerous benefits associated with patients actively reporting their symptoms, as well as letting their healthcare team know how they're doing from home, in making significant improvements in the patients outcomes. of active reporting by patients of their symptoms and letting their healthcare team know how they're doing from their home in making significant improvements in their outcomes. With these benefits in mind, Carvive created CLARA. CLARA is more than just an acronym for Carevive's Longitudinal Assessments and Reporting Assistant. In fact, Keckler describes CLARA as represents serving as someone to represent and assist patients as they navigate and use this Carevive PROmpt program throughout their cancer journey. “She was created to help humanize what could otherwise be an impersonal experience for patients.” Keckler said. “The goal is to keep patients connected,” Still added. “Every clinician's goal is to care for their patients and provide the best possible care that they can, and we think that CLARA really helps to extend those efforts.”

Patients utilizing Carevive's PROmpt engagement tool and ePRO systems now have an assistant they can rely on to help them. Meet CLARA, Carvive's Longitudinal Assessments, and Reporting Assistant. SarahLena Keckler, Director of Product Management at Carevive, and Nadia Still, Carevive's Senior Director of Client Success, walked Oncology and Technology's James Kent through how CLARA came about and how this virtual assistant will make a big difference in patient-reported outcomes. Studies show numerous benefits associated with patients actively reporting their symptoms, as well as letting their healthcare team know how they're doing from home, in making significant improvements in the patients outcomes. of active reporting by patients of their symptoms and letting their healthcare team know how they're doing from their home in making significant improvements in their outcomes. With these benefits in mind, Carvive created CLARA. CLARA is more than just an acronym for Carevive's Longitudinal Assessments and Reporting Assistant. In fact, Keckler describes CLARA as represents serving as someone to represent and assist patients as they navigate and use this Carevive PROmpt program throughout their cancer journey. “She was created to help humanize what could otherwise be an impersonal experience for patients.” Keckler said. “The goal is to keep patients connected,” Still added. “Every clinician's goal is to care for their patients and provide the best possible care that they can, and we think that CLARA really helps to extend those efforts.” “In the digital world, humanizing mascots, or animated mascots like this, are statistically proven to make people feel more comfortable with a product and provide a more meaningful experience,” Keckler said. Carevive believes CLARA can become a patient partner in their journey and will help them utilize the ePRO tool more regularly and effectively.

Jonas is the Co-Founder and Head of Sales at Epro 360, where they help international student find the best universities in the United States and make their application process as simple as studying at home. Prior to that he was an innovation coach for a Fortune 500 company. At his core he is a very humble, thoughtful and creative human being. We met as international students in college, and connected over athletics and both having German origin. As a former college track athlete, he is probably the fastest person I know! So we can help spread this message of healing, please subscribe/follow and take 5 seconds to scroll down and click the 5 stars

Bobby Martins Episode 002: When You Put People In Front Of All Else, That's When The Money Starts Coming In Like Crazy - The Lockbox Podcast with Jeffrey Brogger Listen to the insightful Lockbox episode with Bobby Martins about his real estate background and his tips and lessons. Team Founder, Bobby Martins, Real Estate Broker CRS, GRI, ABR, EPRO, SRES, CDPE, CLHMS, RDC Pro. With nearly 20 years of experience, refining customer service systems yearly and 700+ closed sales, Bobby has become one of San Diego's TOP realtors. His team focuses on delivering extremely high results and delivering first-class service. Bobby's main niche is Move Up and Move Down Buyers which can be complicated because of buying and selling at the same time. Awards and Accomplishments: Real Estate Exec Magazine Top 100 Most influential Real Estate Agents in Southern Cal, 2008-2021, San Diego Magazine, best in client satisfaction. Icon award winner for 2018, 2019, 2020. In 2012 Bobby #1 Keller William's team for Units sold in San Diego, #2 in all of Southern California 2010-2013 CBS Mojo Awards, BEST REALTOR IN SAN DIEGO Inducted into the Re/Max Hall of Fame for career production in 2007 A+ Rating with the BBB. As seen on tv and heard on radio. Top 1% of Realtors nationwide In this episode, we discuss: Building relationships with clients and how to keep them The referral and lead generating basis of real estate, how to grow your clientele and measuring annual volume. Handling multiple projects at once and how to stay on top of them.  Connect with guest  Email: bobby@moveupsandiego.com Text Bobby at: 858-204-7259 Learn more about your ad choices. Visit megaphone.fm/adchoices

这期分享上海生活，以及自驾游的段子~#上绿牌 不限行 有现货#采票惊喜福利，凭这期节目截图到上海吉利汽车任意门店购吉利ePro混动家族车，可享受最高12000的现金优惠，以及38000的附加福利，截至2020年12月31日一定要抓紧了~~谢谢支持，爱你呦~

这期分享上海生活，以及自驾游的段子~#上绿牌 不限行 有现货#采票惊喜福利，凭这期节目截图到上海吉利汽车任意门店购吉利ePro混动家族车，可享受最高12000的现金优惠，以及38000的附加福利，截至2020年12月31日一定要抓紧了~~谢谢支持，爱你呦~

这期分享上海生活，以及自驾游的段子~#上绿牌 不限行 有现货#采票惊喜福利，凭这期节目截图到上海吉利汽车任意门店购吉利ePro混动家族车，可享受最高12000的现金优惠，以及38000的附加福利，截至2020年12月31日一定要抓紧了~~谢谢支持，爱你呦~

这期分享上海生活，以及自驾游的段子~#上绿牌 不限行 有现货#采票惊喜福利，凭这期节目截图到上海吉利汽车任意门店购吉利ePro混动家族车，可享受最高12000的现金优惠，以及38000的附加福利，截至2020年12月31日一定要抓紧了~~谢谢支持，爱你呦~

这期分享上海生活，以及自驾游的段子~#上绿牌 不限行 有现货#采票惊喜福利，凭这期节目截图到上海吉利汽车任意门店购吉利ePro混动家族车，可享受最高12000的现金优惠，以及38000的附加福利，截至2020年12月31日一定要抓紧了~~谢谢支持，爱你呦~

这期分享上海生活，以及自驾游的段子~#上绿牌 不限行 有现货#采票惊喜福利，凭这期节目截图到上海吉利汽车任意门店购吉利ePro混动家族车，可享受最高12000的现金优惠，以及38000的附加福利，截至2020年12月31日一定要抓紧了~~谢谢支持，爱你呦~

AlexanderTapia, Certified Residential Appraiser Associated Residential Appraisers of Southern Arizona 4651 N. 1 Street Avenue, Suite 205 Tucson, AZ 85718 520-318-6000 appraiser@gmail.com About the Host: Carol Nigut, Realtor® ABR, ePro, GRI Your Home for Real Estate at Coldwell Banker Residential Brokerage 2890 E. Skyline Drive #250 Tucson, AZ 85718 520-448-6033 yourhomeforrealestate@gmail.com www.yourhome4realestate.com https://t.co/Ytqo2gMWBB SOCIAL MEDIA: Facebook | Google | Instagram | LinkedIn | YouTube | Zillow | Originally from the Chicago area, Carol […] The post YHFRE E9: Appraisals in the Age of Covid-19 appeared first on Business RadioX ®.

In Episode 38 we catch up with Nicole Hajdu Real Estate Broker. Nicole Hajdu may have been in the real estate industry for 10 years, but she still has the determination and hustle of someone just starting in the business. It takes true growth, resilience, instinct and tenacity to make it in this business, and Hajdu has them in spades. “I’m always seeking opportunities to move forward and grow my business,” she says. Hajdu works with sellers, investors and buyers within Chicago and the surrounding suburbs, in addition to recruiting and training new hires. Influenced by her entrepreneurial parents and her father’s ability to further support his family through real estate investment, Hajdu got her license in the early 2000s after shifting from a job as an account executive in corporate advertising and TV production to one at a startup residential remodeling company. “It was the perfect mix of expertise,” she says. “It was the perfect opportunity to set myself apart from the competition and make a difference for my clients and [have] the opportunity to make that same difference for my family that my father made for his.” Since then, Hajdu’s earned a reputation as a top producer in Chicago, earning recognition from her employers in 2011, 2013 and 2014 for her sales numbers, as well as the 2016 Top Producer award from the Chicago Association of Realtors. Hajdu attributes her success to her extensive knowledge, the level of personalized prep work she does for everyone she works with, and her attentiveness to her clients’ needs. During the past year, Hajdu doubled her business, and now says 90 percent of the people she works with are referrals and repeat clients. “This shows the importance of setting yourself apart and being seen as the go-to for real estate,” she says. Hajdu is a member of the Chicago Association of Realtors, the Illinois Association of Realtors and the National Association of Realtors, and has several designations including ABR, CNE, BPO, SFR, GRI and ePro. When she’s not working, she loves reading, horseback riding, seeking adventure and traveling with her family. To contact Nicole Hajdu enail her direct at nhajdu@atproperties.com. ................................................................................................................................................................................................. Check out Lupita V's, "3 Easy Steps to Feel CALM NOW During COVID-19 & Meditation video here: https://youtu.be/a0TNxFS0qOg Make sure to subscribe to her YouTube channel NOW! ................................................................................................................................................................................................. If you're a VIP, Executive, Pro Athlete, or Pastor and you're looking for an experienced coach to help you navigate your role more efficiently, contact David Ubeda at david@mrdeu.com.

Today we’re in the midst of the pandemic and virtual clinical trials are likely going to be a big part of our post-COVID-19 world.  In this interview, I had the pleasure of speaking with Mike Novotny about virtual trials i.e. decentralized trials.  Mike is the founder and CEO of Medrio. Mikes brings over 20 years of experience in research and software to his eClinical SaaS vision.  Prior to founding Medrio, Mike was president of Ninaza, an EDC software company, and had previously held roles as a research associate at the U.N. and a manager of the fraud database at VISA.  He holds a BA from Stanford University and an MBA from Columbia University. Mike founded Medrio in 2005 in San Francisco. I hope you enjoy my conversation with Mike. What is a decentralized or virtual clinical trial?  Benefits of a virtual clinical trial in patient recruitment The current model of clinical trials where recruitment is done through the doctor What does it mean to conduct a decentralized or virtual clinical trial? Case Study - CNS trials and how they can benefit from going virtual A limited number of patients (smaller patient pool)  Use of social media to find eligible patients The patient does not need to travel to the doctor’s office, the caregiver goes to the patients home Medrio as a technology provider for virtual studies  eConsent Electronic data capture (EDC) Direct Data Capture (DDC) Randomization with EDC  Case Study - Cholera vaccine study in Yemen Collecting clinical data without an internet connection The downside of paper data collection DDC is a subset of eSource eSource can be EHR, DDC, ePRO, eCOA Future of EDC as we get more integrated with EHR Patient recruitment New efforts through AI Efforts through social media Genetic profiling Enabling participants to be anywhere in the world to participate in the trial Barriers to adoption Importance of monitoring in a virtual clinical trial to prevent fraud  The downside of a virtual clinical trial is the implementation Patients want their doctor to be involved New tools lead to new complications The trial does not match the decentralized model Common concerns from Sponsors Storing data on the cloud is risky Offline data management - what if the wifi goes down or there is no cellular signal Data loss - what if the tablet break Thinking in terms of relative risk Clinical trials fail 90% of the time Trial data is never looked at again Need to standardize audits to bring the cost down and improving the quality of the audit Medrio is focused on:  Speed Great tool for early phase diagnostic and device studies Customer service measured using net promoter scores eSource - Direct Data Capture (DDC) Optimism, focusing on the positive, not watching/ reading the news

Welcome back to CEO Secrets! Today our guest is a Real Estate tycoon in the Tyler market. Please welcome, Danny Burks, Owner/President of The Burks Home Team Inc. Danny is a Broker in Texas, ePRO certified with National Association of Realtors, Graduate Realtor Institute, and is a Certified Home Marketing Specialist. With over 15 years experience in residential real estate, Danny has been involved with over $400,000,000 in residential sales in the East Texas market. Let's learn today from Danny how he is able to grow his team and continue to thrive in their territory. Top Takeaways: 1. The secret to growing your business (3:30) 2. Danny's biggest Aha (6:35) 3. Lessons to teach your people to become great leaders (8:36) 4. Biggest mistake young leaders are making today (23:17) 5. Living life to the fullest vs making short term sacrifices for something big (32:17) Episode Transcript: https://docs.google.com/document/d/1s6fCjnJ7_626ndCoBkY-4KhEmYMqFf31iIU5IcDHbAo/edit?usp=sharing

ep. 42: Setting up your team JP talks with Lorre Wilson on how to set up a successful team. Lorre is the West Virginia Broker, opening the last state for EXP. Licensed for over 10 years Lorre sold over $12 mill in volume before becoming the broker. Last year sold $7.5 mill then Created a team to continue serving clients. Also licensed in Ohio & Kentucky. ABR, GRI, relocation specialist, ePro. Shout out to Lorre or send a referral Contact information: Lorre Wilson, 304-690-1236 / wv.broker@exprealty.net And a link to an item of value for our audience (a sharable link or web url). Ie. checklist, forms, spreadsheet, tool...etc www.MyListAndSell.com www.HomeBuying101.net www.RealEstate4theTriState.com Success Agent Podcast here on our Facebook page: https://www.facebook.com/successagentpodcast Give us a 5 Star review on Itunes https://apple.co/2DIT7hB Give JP a Shout out about the episode or shoot him an email: James.Fluellen@gmail.com . . Host: JP Fluellen - Team leader of the Titan Real Estate Team @ exp realty based in Cheyenne, WY and real estate business coach. Reach out to JP for a free 30-minute coaching call. 307-772-1184 or Go to www.titanelitecoaching.com . Connect WIth JP: http://clyxo.com/jpfluellen Give your Buyers the gift of knowlege: Check out My BOOK! The Real Estate Brain: 7 Hacks for buying like a Pro! https://www.amazon.com/…/dp/109191396X/ref=tmm_pap_swatch_0… . . Follow us: - Facebook: http://bit.ly/2S8xnQc - LinkedIn: http://bit.ly/2X5O16M - Youtube: http://bit.ly/2Gtjnz9 - Itunes: https://apple.co/2DIT7hB - Spotify: https://spoti.fi/2HIrrxs - AnchorFM: http://bit.ly/2CUDS3H - Stitcher: http://bit.ly/2Su8Ai . . #RealEstate #titanreteam #Realtor #RealEstateBusiness#Tianelitecoach #RealEstatePodcast #RealEstateBroker#RealEstateLife #exprealtyproud

Real Estate Profession | Prepare Yourself for Success in Real Estate By the age of twenty-five, Leigh Brown had already worked three different full-time jobs. She did stints as a bar manager, a salesperson, and a stockbroker before finally heading back to the drawing board to conjure up a long term play. Leigh’s father was in the real estate profession, and years before any of this, he made Leigh get a license in case she wanted to get into the industry down the road—that is exactly what she did! Twenty years later, Leigh is still thriving in the real estate business and loves every aspect of it. From the relationship building and client management to the countless niches in which you can build a career, this is the best place to be! Your Education Never Ends There is no profession that rewards people who are willing to put in the legwork and get creative like the real estate profession. You can come into this industry with any background, find a sense of discipline, and accomplish almost anything you put your heart and mind to. But you also need to be thoroughly prepared. When Leigh got started at twenty-five, her father made her sustain a rigorous education process before she got hands-on with clients. Now, that doesn’t mean you can’t achieve success by learning as you go—it just means there is an immeasurable amount of value in mentorship and the process of learning by example. Get out there and find someone to talk to; take advantage of every resource that resonates with the goals you set for yourself. Your education never ends in real estate. Run Your Business How YOU Want to Run It Once we move our pride and egos aside, we have the potential to be amazing. But admitting that you don’t know something can be a hard pill to swallow. Being in the real estate profession means you are in a constant learning process, however, as you gain more experience, you can start to run your business how YOU want to run it. This whole thing can be fun and easy if you take the wheel and start acting like the CEO of your business! So, set boundaries and unplug once in a while, because you are not the employee of someone else’s agenda. If you are available 24/7 you can’t enjoy the freedom that drew you to real estate in the first place! But the best part is, you also have the power to change that.  About Leigh Brown Leigh stepped into the real estate world in 2000, joining forces with her father, Darrell Thomas, who had a successful residential real estate company. As a native of Cabarrus County in North Carolina, Leigh has a thorough understanding and knowledge of the Queen City and the thriving, unique communities that surround the fair city. Her business thrives on repeat business and solid client relationships, and she is not ashamed to tout that over 70% of her clients are referrals. Leigh lives in Harrisburg, a NE suburb of Charlotte, with her husband Steve and her two middle school children. In her (rare) free time, she enjoys running, playing piano, and volunteering for Meals On Wheels. A proud graduate of UNC Chapel Hill, Leigh feels that continuous education is of the utmost importance. Her current designations include: – ABR (Accredited Buyer Representative), AHWD (At Home With Diversity designation), CIPS (Certified International Property Specialist), CRS (Certified Residential Specialist), CLHMS (Certified Luxury Home Marketing Specialist), CIPS (Certified International Property Specialist), MilRES (certified to assist with military housing), CDPE (Certified Distressed Property Expert), ecoBroker (knowledge of green building options), ePRO (technology skills), FiveStar (foreclosure expertise), SFR (Short Sale and Foreclosure Resource), SRES (Seniors Real Estate Specialist). What You Will Learn: Leigh’s backstory and her journey into the real estate profession How Leigh overcame the challenges of entering the world of real estate at age twenty-five  Why Leigh chose to educate herself through conferences and mentors before working directly with clients How Leigh manages the constantly active lines of communication that come with modern connectivity The importance of setting boundaries and running your business how YOU want to run it How Leigh manage her energy to bring  the best version of herself to every interaction Additional Resources: Books: Outrageous Authenticity: You Are Your Best Sales Weapon The Seven Deadly Sins of Sales: and the Deceptively Simple Strategies to Solve Them Peeling the Onion (2020) Podcast: Crazy Sh*t in Real Estate  Twitter: @LeighBrown Facebook: www.facebook.com/LeighBrownSpeaker/ Instagram: instagram.com/leighsellsclt LinkedIn: linkedin.com/in/leighthomasbrown Website: https://www.leighsells.com/ 5-Step Guide to More Referrals Book Recommendations: The Jackass Whisperer Insults and Comebacks for All Occasions Who Not How (October 2020) A Nation of Realtors A Man Called Ove 3000 Questions About Me

Listen the Full legendary Eminem concert shot in Madison Square Garden in 2005 here on Unplugged Live Concerts! Team UNPLUGGED

In this episode, I Interview Shauna Games (female) Fifa content creator. We talk about, how EA global series should include female ePro players, the season of Man U, challenges when streaming and how to keep the chat room light and fun?! Tune in

Integrating patient-reported outcomes (PROs) into clinical practice is an increasingly promising strategy for improving patient engagement, symptom control, and clinical outcomes, including reducing avoidable hospitalizations and emergency room visits. Furthermore, recent data also shows that PRO-based proactive symptom monitoring may increase cancer patient survival. Now is the time to engage in discussions on practical applications of ePRO and finding the right balance of people, process, and technology. Recent advances in technology and survey methods may provide a solution to capturing PROs. There is evidence that the PRO approach can improve patient-clinician communication, ultimately improving a patient’s overall quality of life. An ePRO system can play a key role in clinical decision-making, as symptom management would improve and clinicians would be more aware of how a patient feels. PROs are finding a significant place in healthcare quality metrics, and PROs are sometimes thought to be more reliable than clinician-reported data. The challenge continues to be adopting service workflows to collect this information from patients, and electronic PROs (ePROs) have definitely enhanced this process. In this webinar recording, you will hear from a panel of experts discuss: Latest ePRO study data Lessons learned from ePRO studies in oncology Implementation science for ePROs How a cancer center is innovating in its approach to proactive symptom monitoring How Carevive technology can facilitate capturing ePROs by monitoring the symptoms patients experience and alerting providers when interventions are necessary for at-risk patients --- Recorded live on January 16, 2019.

Topics: strength, asymmetry, gait, thegaitguys, gaitanalysis, achilles, windlass mechanism Links to find the podcast: Look for us on iTunes, Google Play, Podbean, PlayerFM and more. Just Google "the gait guys podcast". Our Websites: www.thegaitguys.com doctorallen.co summitchiroandrehab.com shawnallen.net Our website is all you need to remember. Everything you want, need and wish for is right there on the site. Interested in our stuff ? Want to buy some of our lectures or our National Shoe Fit program? Click here (thegaitguys.com or thegaitguys.tumblr.com) and you will come to our websites. In the tabs, you will find tabs for STORE, SEMINARS, BOOK etc. We also lecture every 3rd Wednesday of the month on onlineCE.com. We have an extensive catalogued library of our courses there, you can take them any time for a nominal fee (~$20). Our podcast is on iTunes and just about every other podcast harbor site, just google "the gait guys podcast", you will find us. Where to find us, the podcast Links: iTunes page: https://itunes.apple.com/us/podcast/the-gait-guys-podcast/id559864138?mt=2 Google Play: https://play.google.com/music/m/Icdfyphojzy3drj2tsxaxuadiue?t=The_Gait_Guys_Podcast   Topics and links: A new neuron has been discovered and named. The rosehip cell https://www.wired.com/story/meet-the-rosehip-cell-a-new-kind-of-neuron/ Strength does matter in our opinion, especially when it is stacked onto asymmetry and dysfunction. https://www.ncbi.nlm.nih.gov/pubmed/26566993 Am J Sports Med. 2016 Jan;44(1):105-12. doi: 10.1177/0363546515611632. Epub 2015 Nov 13. Is Hip Abduction Strength Asymmetry Present in Female Runners in the Early Stages of Patellofemoral Pain Syndrome? Plastaras C1, McCormick Z2, Nguyen C3, Rho M2, Nack SH2, Roth D4, Casey E5, Carneiro K6, Cucchiara A1, Press J2, McLean J7, Caldera F8. Positive Work Contribution Shifts from Distal to Proximal Joints during a Prolonged Run SANNO, MAXIMILIAN1,2; WILLWACHER, STEFFEN1,3; EPRO, GASPAR1,4; BRÜGGEMANN, GERT-PETER1,2,3 Medicine & Science in Sports & Exercise: December 2018 - Volume 50 - Issue 12 - p 2507–2517 https://journals.lww.com/acsm-msse/Citation/2018/12000/Positive_Work_Contribution_Shifts_from_Distal_to.16.aspx Influence of the windlass mechanism on arch-spring mechanics during dynamic foot arch deformation Lauren Welte, Luke A. Kelly, Glen A. Lichtwark, Michael J. Rainbow Published 15 August 2018.DOI: 10.1098/rsif.2018.0270 http://rsif.royalsocietypublishing.org/content/15/145/20180270 Med Sci Sports Exerc. 2018 Dec;50(12):2500-2506. doi: 10.1249/MSS.0000000000001710. Reducing Impact Loading in Runners: A One-Year Follow-up. Bowser BJ1, Fellin R2, Milner CE3, Pohl MB4, Davis IS5. https://www.ncbi.nlm.nih.gov/pubmed/29975300/ Achilles tendon structure differs between competitive distance runners and nonrunners despite no clinical signs or symptoms of midsubstance tendinopathy Todd J. Hullfish,Kenton L. Hagan, Ellen Casey, Josh R. Baxter 09 Aug 2018https://doi.org/10.1152/japplphysiol.00012.2018 https://www.physiology.org/doi/abs/10.1152/japplphysiol.00012.2018 Our obligatory disclaimer: This podcast is for general informational purposes only. It does not constitute the practice of medicine, nursing, rehab, treatment, therapy recommendations or anything of the sort. This podcast should not replace proper medical advise that should only be attained through proper medical channels that would entail a full medical and/or biomechanical physical examination and/or appropriate diagnostic testing. No doctor-patient relationship is formed by listening to this podcast or any information gleaned from our writings or social media work. The use of this information and the materials linked to the podcast is taken at the users own risk. This podcast and the content shared is not intended to replace or be a substitute for appropriate professional medical advise diagnosis or treatment. Users should not disregard or delay obtaining medical advice for any condition they have and should seek the advice and assistance from their providers for any such conditions.

Sharon Gregresh & Peter Mingils on Real Estate in Canada Radio Show. Sharon Gregresh has been in the Real Estate market in Canada for a long time. Listen in on  Building Fortunes Radio to pick up some real estate tips and investment strategies www.buildingfortunesradio.com  SHARON GREGRESH, REALTOR, ePRO, SRS, ABR, CRS Century 21 Masters  780-238-5537 mobile 780-460-8558 office 780-702-9999 desk 780-702-1115 fax  Sharon@PropertyFusion.ca www.PropertyFusion.ca

Pros and Cons of todays industry and what would you change

Carolyn Steele Gray, in interview with Ross Upshur, discusses how her academic journey shaped her perspectives in understanding patient needs, health policy, organization and provider level issues and how to use that understanding to deliver a better care. The latter, she adds, necessitates a realistic approach of how to harness e-health technologies to deliver care, especially to patients with complex care needs. Carolyn discusses how technology in health is not the silver bullet to healthcare questions and its implementation is embedded within complex social layers, affected by people’s feelings about it; policy issues surrounding it; and how organizations treat it. Carolyn describes the value of adopting a user-centred design evaluation approach used to develop the ePRO tool; describing how it evolved from a tool intended to collect patient-reported outcome measures to one that enables patient-centred goal-oriented care within primary care settings. The talk addresses some of the current challenges in the use of e-health technologies in the healthcare system highlighting tensions faced by researchers and adopters. Carolyn is a Scientist at the Bridgepoint Collaboratory for Research and Innovation at the Lunenfeld-Tanenbaum Research Institute, Assistant Professor at the Institute of Health Policy, Management and Evaluation (University of Toronto), as well as an investigator with the Health System Performance Research Network (University of Toronto). Carolyn’s research focuses on the role of health information technology in supporting person-centred care delivery for individuals with complex care needs. Her research explores how technology can be leveraged to enable implementation and sustainability of innovative models of care as a means to support health system transformation. Carolyn received her PhD in Health Policy from the University of Toronto (2013), and a Master’s in Public Policy and Administration from Ryerson University (2008). Prior to her current role as a Scientist, she was a postdoctoral fellow working at the University of Toronto and the Health System Performance Research Network. For a full bio, please follow this link. Carolyn has published work in the areas of eHealth and mHealth, organizational change, health policy and patient-centred care delivery. Some of Carolyn’s papers indexed in PubMed so far.

Michael Bull / Bull Realty Michael Bull is a writer, speaker, trainer, consultant, business coach, radio show host, and active commercial real estate broker. He has been involved in $4 billion in sales and lease transactions over a successful 30 year career. He has earned the prestigious CCIM designation as well as the CRB and ePro […] The post Michael Bull of Bull Realty appeared first on Business RadioX ®.

INC Research is partnering with invivodata to add ePRO to its offering, selecting the eClinical firm over its competitors in part because it understands the “aggressive” approach the CRO takes.

Brian Epro from iMakeNews Inc. returns to discuss the do's and don'ts of e-mail communication with customers — including some of the most common mistakes, how to keep people from opting out and managing your reputation with ISPs.

Maintaining ongoing lines of communication with customers is vital in today's automotive market. Brian Epro, director of the automotive services group at iMakeNews Inc. shares his experience on what works, what doesn't how to build on your relationships with your customers.